肺结核基层合理用药指南

2020-10-20 中华医学会 中华全科医师杂志.2020,19(10):891-899.

肺结核是指发生在肺组织、气管、支气管和胸膜的结核,包括肺实质的结核、气管、支气管结核和结核性胸膜炎,占各器官结核病总数的80%~90%。飞沫传播是肺结核最重要的传播途径。临床表现为咳嗽、咳痰,可伴咯血

中文标题:

肺结核基层合理用药指南

发布机构:

中华医学会

发布日期:

2020-10-20

简要介绍:

肺结核是指发生在肺组织、气管、支气管和胸膜的结核,包括肺实质的结核、气管、支气管结核和结核性胸膜炎,占各器官结核病总数的80%~90%。飞沫传播是肺结核最重要的传播途径。临床表现为咳嗽、咳痰,可伴咯血、痰中带血,肺外可表现为低热、乏力、盗汗、食欲减退、体重减轻等。

 

下载附件:

(因为版权问题,不支持下载)

评论区 (18)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1222446, encodeId=cde31222446f1, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16895728910, createdName=自此烟雨落盛京, createdTime=Wed May 25 21:36:41 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204660, encodeId=e5281204660ed, content=学习了<a href='/topic/show?id=08a382281a1' target=_blank style='color:#2F92EE;'>#肺结核#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82281, encryptionId=08a382281a1, topicName=肺结核)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b945401957, createdName=ms1000001203941975, createdTime=Mon Mar 21 16:42:30 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183101, encodeId=195711831013b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdb55558156, createdName=马小胖, createdTime=Tue Jan 11 09:25:27 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065638, encodeId=a0971065638a2, content=适用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc365583438, createdName=ms9000000623894544, createdTime=Sun Oct 31 23:06:03 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008430, encodeId=a038100843062, content=适用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdb55558156, createdName=马小胖, createdTime=Mon Aug 16 20:16:16 CST 2021, time=2021-08-16, status=1, ipAttribution=)]
    2022-05-25 自此烟雨落盛京

    谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1222446, encodeId=cde31222446f1, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16895728910, createdName=自此烟雨落盛京, createdTime=Wed May 25 21:36:41 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204660, encodeId=e5281204660ed, content=学习了<a href='/topic/show?id=08a382281a1' target=_blank style='color:#2F92EE;'>#肺结核#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82281, encryptionId=08a382281a1, topicName=肺结核)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b945401957, createdName=ms1000001203941975, createdTime=Mon Mar 21 16:42:30 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183101, encodeId=195711831013b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdb55558156, createdName=马小胖, createdTime=Tue Jan 11 09:25:27 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065638, encodeId=a0971065638a2, content=适用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc365583438, createdName=ms9000000623894544, createdTime=Sun Oct 31 23:06:03 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008430, encodeId=a038100843062, content=适用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdb55558156, createdName=马小胖, createdTime=Mon Aug 16 20:16:16 CST 2021, time=2021-08-16, status=1, ipAttribution=)]
    2022-03-21 ms1000001203941975

    学习了#肺结核#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1222446, encodeId=cde31222446f1, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16895728910, createdName=自此烟雨落盛京, createdTime=Wed May 25 21:36:41 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204660, encodeId=e5281204660ed, content=学习了<a href='/topic/show?id=08a382281a1' target=_blank style='color:#2F92EE;'>#肺结核#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82281, encryptionId=08a382281a1, topicName=肺结核)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b945401957, createdName=ms1000001203941975, createdTime=Mon Mar 21 16:42:30 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183101, encodeId=195711831013b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdb55558156, createdName=马小胖, createdTime=Tue Jan 11 09:25:27 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065638, encodeId=a0971065638a2, content=适用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc365583438, createdName=ms9000000623894544, createdTime=Sun Oct 31 23:06:03 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008430, encodeId=a038100843062, content=适用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdb55558156, createdName=马小胖, createdTime=Mon Aug 16 20:16:16 CST 2021, time=2021-08-16, status=1, ipAttribution=)]
    2022-01-11 马小胖

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1222446, encodeId=cde31222446f1, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16895728910, createdName=自此烟雨落盛京, createdTime=Wed May 25 21:36:41 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204660, encodeId=e5281204660ed, content=学习了<a href='/topic/show?id=08a382281a1' target=_blank style='color:#2F92EE;'>#肺结核#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82281, encryptionId=08a382281a1, topicName=肺结核)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b945401957, createdName=ms1000001203941975, createdTime=Mon Mar 21 16:42:30 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183101, encodeId=195711831013b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdb55558156, createdName=马小胖, createdTime=Tue Jan 11 09:25:27 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065638, encodeId=a0971065638a2, content=适用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc365583438, createdName=ms9000000623894544, createdTime=Sun Oct 31 23:06:03 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008430, encodeId=a038100843062, content=适用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdb55558156, createdName=马小胖, createdTime=Mon Aug 16 20:16:16 CST 2021, time=2021-08-16, status=1, ipAttribution=)]
    2021-10-31 ms9000000623894544

    适用

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1222446, encodeId=cde31222446f1, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16895728910, createdName=自此烟雨落盛京, createdTime=Wed May 25 21:36:41 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204660, encodeId=e5281204660ed, content=学习了<a href='/topic/show?id=08a382281a1' target=_blank style='color:#2F92EE;'>#肺结核#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82281, encryptionId=08a382281a1, topicName=肺结核)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b945401957, createdName=ms1000001203941975, createdTime=Mon Mar 21 16:42:30 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183101, encodeId=195711831013b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdb55558156, createdName=马小胖, createdTime=Tue Jan 11 09:25:27 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065638, encodeId=a0971065638a2, content=适用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc365583438, createdName=ms9000000623894544, createdTime=Sun Oct 31 23:06:03 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008430, encodeId=a038100843062, content=适用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdb55558156, createdName=马小胖, createdTime=Mon Aug 16 20:16:16 CST 2021, time=2021-08-16, status=1, ipAttribution=)]
    2021-08-16 马小胖

    适用

    0

拓展阅读

肺结核影像学及分级诊断专家共识

中华医学会放射学分会(CSR,chinese society of radiology) · 2018-05-30

肺结核基层诊疗指南(2018年)

中华医学会(CMA,Chinese Medical Association) · 2019-08-30

抗肺结核药物临床试验技术指导原则

国家药品监督管理局药品审评中心(CDE) · 2020-12-31

流动人口肺结核患者管理指南

中国防痨协会(Chinese Antituberculosis Association) · 2021-01-30

肺结核影像诊断标准

中华医学会放射学分会(CSR,chinese society of radiology) · 2021-01-30

军事飞行人员肺结核医学鉴定操作指南(2022)

空军特色医学中心 · 2022-03-31